Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.
Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice to support the introduction of Rotarix® to replace RotaTeq® in specified Australian states (Western Australia, South Australia, Victoria and Queensland) from 1 July 2017.
The Australian Government launched the 'Get the facts about immunisation' campaign in August 2017 to encourage Australian parents and carers to get their kids vaccinated.
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
The Australian Government is committed to immunisation and to ensuring Australia has the best possible vaccination program underpinned by sound evidence and effective vaccines.
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.
Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.
All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.
Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.
Australia’s therapeutic goods regulator is implementing new arrangements to simplify and improve the handling of complaints about the advertising of medicines and medical devices to the public.
Aboriginal and Torres Strait Islander children will be able to receive the seasonal influenza vaccine for free under the National Immunisation Program from 2015.
A national immunisation coverage target provides a goal against which Australia can measure its immunisation coverage. The Global Vaccine Action Plan 2011-2020 encourages countries to demonstrate a commitment to immunisation.
Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.
The Community should be reassured that our drinking water is safe.
The Australian Health Protection Principal Committee (AHPPC) discussed the COVID-19 situation in New Zealand and the current 72 hour travel pause on green safe travel zone flights from New Zealand to Australia at its meeting on 28 January 2021.